anti-miRNA-145 TheraSilence (Celsion/University of South Alabama)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-miRNA-145 TheraSilence (Celsion/University of South Alabama)
Drug Alias Nameanti-miRNA-145 (Celsion/University of South Alabama)anti-miRNA-145 (EGEN/University of South Alabama)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEgen IncUniversity Of South AlabamaImunon Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Arterial Hypertension

Other Information

ATC CodeN/A
Related LinksN/A